Background: C3 glomerulopathy (C3G) is characterized by predominant C3 deposits in glomeruli and dysregulation of the alternative pathway of complement. Half of C3G patients have a C3 nephritic factor (C3NeF). C3G incorporated entities with a range of features on microscopy including dense deposit diseases (DDD) and C3 glomerulonephritis (C3GN). The aim of this work was to study children cases of C3G associated with C3NeF.
Methods: We reviewed 18 cases of C3G with a childhood onset associated with C3NeF without identified mutations in CFH, CFI, and MCP genes.
Results: Clinical histories started with recurrent hematuria for seven patients, nephrotic syndrome for four, acute post-infectious glomerulonephritis for three and acute renal failure for four. Twelve patients had a low C3 at first investigation. Kidney biopsy showed ten C3GN and eight DDD. Twenty-three percent of the patients tested presented elevated sC5b9. Seven patients relapsed 3 to 6 years after the onset. At the end of follow-up, two patients were under dialysis, 11 had a persistent proteinuria, five had none; four patients did not follow any treatment. Steroids were first used in 80 % of cases.
Conclusions: C3NeF associated C3G has a heterogeneous presentation and outcome. Anti-proteinuric agents may control the disease during follow-up, even after nephrotic syndrome at the onset. The efficiency of immunosuppressive therapy remains questionable.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00467-013-2605-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Lupus Nephritis and Chronic Kidney Disease: A Scoping Review.
Nephrology (Carlton)
January 2025
Division of Nephrology, School of Clinical Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong SAR.
Prevention of end-stage kidney disease (ESKD) is a major objective in the management of patients with lupus nephritis (LN). Chronic kidney disease (CKD) of variable severity is common in these patients, but recent literature has mostly focused on novel immunosuppressive treatments for acute LN, while the data on CKD is relatively limited. This scoping review aims to summarise available data on the prevalence and risk factors for CKD in patients with LN.
View Article and Find Full Text PDFDe Novo C3 Glomerulonephritis of Allograft Associated With Factor H Autoantibody in a Patient with Systemic Lupus Erythematosus: A Case Report.
Transplant Proc
December 2024
Division of Nephrology and Hypertension, Keck School of Medicine of USC, Los Angeles, California. Electronic address:
Article Synopsis
- * The dysregulation of the complement pathway can be triggered by genetic mutations or autoantibodies, leading to further complications like C3 glomerulopathy and thrombotic microangiopathies.
- * The case study discussed involves a patient with Systemic Lupus Erythematosus (SLE) who developed C3GN in a kidney transplant, highlighting the need for more research on treatment options for this rare condition.
Acquired and genetic drivers of C3 and C5 convertase dysregulation in C3 glomerulopathy and immunoglobulin-associated MPGN.
Nephrol Dial Transplant
November 2024
Department of Immunology, Assistance Publique- Hôpitaux de Paris (AP-HP), Georges Pompidou European Hospital, Paris, France.
Dysregulation of the alternative pathway of complement plays a central role in the pathophysiology of C3 Glomerulopathy (C3G). Various autoimmune and genetic factors targeting the alternative pathway have been associated to both C3G and primary Immunoglobulin-associated Membranoproliferative Glomerulonephritis (Ig-MPGN), suggesting shared pathophysiological mechanisms. This review highlights the wide range of disease drivers identified that mainly target components or protein complexes of the alternative pathway, both in C3G and Ig-MPGN.
View Article and Find Full Text PDFImmunoregulatory role of AC007278.3 and HOTAIR long non-coding RNAs in lupus nephritis: potential biomarkers and therapeutic targets.
Mol Biol Rep
October 2024
Department of Biology, Faculty of Science, Urmia University, Urmia, 5756151818, Iran.
Article Synopsis
- - The study investigates the role of long non-coding RNAs (lncRNAs), specifically AC007278.3 and HOTAIR, in regulating the immune response in systemic lupus erythematosus (SLE), a type of autoimmune disease, and their potential as diagnostic biomarkers.
- - Blood samples from SLE patients and healthy controls were analyzed, revealing significant upregulation of the lncRNAs and their related protein-coding genes, TNF-α and IL18RAP, in the patients.
- - The lncRNAs showed strong correlation with the target genes and demonstrated high diagnostic potential, with values of 0.89 for AC007278.3 and 0.86 when combined with H
Performance of the Systemic Lupus Erythematosus Risk Probability Index (SLERPI) in a cohort of Colombian population.
Clin Rheumatol
November 2024
Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Carrera 24 # 63-C- 69, 110010, Bogota, D.C, Colombia.
Article Synopsis
- The study aimed to assess how well the Systemic Lupus Erythematosus Risk Probability Index (SLERPI) performs in diagnosing systemic lupus erythematosus (SLE) among Colombian patients, comparing it with established diagnostic criteria.
- Researchers collected data from 435 SLE patients and 430 control subjects with other autoimmune diseases, finding that SLE patients had significantly higher SLERPI scores, with key influential factors including immunological disorders and specific skin symptoms.
- SLERPI showed high sensitivity in identifying SLE, particularly for hematological and renal forms, but had lower specificity compared to traditional criteria, indicating it might be more effective in ruling out SLE rather than confirming it.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!